These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19505864)

  • 1. Treatment of palmoplantar pustulosis with arotinoid ethylester.
    SHAN SJ; LI YH; ZHANG G; XIAO T; LI C; WEI H; CHEN HD
    Eur J Dermatol; 2009; 19(5):474-7. PubMed ID: 19505864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study.
    Reitamo S; Erkko P; Remitz A; Lauerma AI; Montonen O; Harjula K
    Arch Dermatol; 1993 Oct; 129(10):1273-9. PubMed ID: 8215491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both low-dose arotinoid ethylester and acitretin are effective in the treatment of familial erythrokeratodermia variabilis.
    Zhang L; Hong Y; Zheng S; Huo W; Qi R; Geng L; Chen HD; Gao XH
    Dermatol Ther; 2014; 27(4):240-3. PubMed ID: 24754264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study.
    V'lckova-Laskoska MT; Caca-Biljanovska NG; Laskoski DS; Kamberova SJ
    Dermatol Ther; 2009; 22(1):85-9. PubMed ID: 19222520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients.
    Adişen E; Tekin O; Gülekon A; Gürer MA
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):814-9. PubMed ID: 19470063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept in the treatment of palmoplantar pustulosis.
    Bissonnette R; Poulin Y; Bolduc C; Maari C; Provost N; Syrotuik J; Poulin-Costello CM; Nigen S
    J Drugs Dermatol; 2008 Oct; 7(10):940-6. PubMed ID: 19112757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsoriatic activity of a new synthetic retinoid. The arotinoid RO 13-6298.
    Tsambaos D; Orfanos CE
    Arch Dermatol; 1983 Sep; 119(9):746-51. PubMed ID: 6614962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for chronic palmoplantar pustular psoriasis.
    Marsland AM; Griffiths CE
    Skin Therapy Lett; 2001 Nov; 6(12):3-5. PubMed ID: 11753536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arotinoid ethyl ester (Ro 13-6298): a long term pilot study in various dermatoses.
    Mérot Y; Camenzind M; Geiger JM; Saurat JH
    Acta Derm Venereol; 1987; 67(3):237-42. PubMed ID: 2442937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arotinoid-ethylester. Effectiveness in refractory cutaneous T-cell lymphoma.
    Hoting E; Meissner K
    Cancer; 1988 Sep; 62(6):1044-8. PubMed ID: 3409182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
    Yamamoto T
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for palmoplantar pustulosis.
    Adişen E; Gürer MA
    Clin Exp Dermatol; 2010 Apr; 35(3):219-22. PubMed ID: 19874337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arotinoid Ro 13-6298 and etretin: two new retinoids inferior to isotretinoin in sebum suppression and acne treatment.
    Harms M; Philippe I; Radeff B; Masouyé I; Geiger JM; Saurat JH
    Acta Derm Venereol; 1986; 66(2):149-54. PubMed ID: 2424239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term colchicine for recalcitrant palmoplantar pustulosis: treatment outcome in 3 patients.
    Wong SS; Tan KC; Goh CL
    Cutis; 2001 Sep; 68(3):216-8. PubMed ID: 11579788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
    Passeron T; Perrot JL; Jullien D; Goujon C; Ruer M; Boyé T; Villani AP; Quiles Tsimaratos N
    JAMA Dermatol; 2024 Feb; 160(2):199-203. PubMed ID: 38054800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis.
    Fujisawa T; Tawada C; Mizutani Y; Doi T; Yoshida S; Ogura S; Seishima M
    Ther Apher Dial; 2014 Jun; 18(3):238-43. PubMed ID: 24965289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pustulosis palmo-plantaris. Clinical and histological changes during etretin (acitretin) therapy.
    Schröder K; Zaun H; Holzmann H; Altmeyer P; el-Gammal S
    Acta Derm Venereol Suppl (Stockh); 1989; 146():111-6. PubMed ID: 2532841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.